Clinical Trial Update: Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and efficacy of BLEX 404 oral liquid in combination with pemetrexed and cisplatin for non-squamous non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BLEX 404
• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Rgene Corporation | Conditions: Nonsquamous Nonsmall Cell Neoplasm of Lung | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING